At 6:40 on a Tuesday morning, a dispatcher in a two-room office outside Columbus stared at a board that had already gone wrong. Three drivers had called in sick, a wheelchair van was in the shop, and a dialysis patient who needed to be at the clinic by 8:00 had no ride at all. The vans existed. The drivers, most of them, existed. What did not exist, in usable form, was a plan that could bend: which trip could move, which vehicle could substitute, which patient could wait an hour without harm. By 7:15 the dispatcher had rebuilt the morning by hand, on paper, and two patients still missed their chairs.
That morning is the whole market in miniature. Non-emergency medical transportation, or NEMT, is usually described as a vehicle business. It is not. It is a scheduling business that happens to own vehicles. The global market was estimated at $16.2 billion in 2024 and is projected to reach $24.3 billion by 2030, a compound annual growth rate of 7.0%, according to ResearchAndMarkets. Growth of that shape does not come from buying more vans. It comes from using the vans already on the road with fewer empty miles, fewer missed pickups, and fewer trips that cost more to run than the contract pays.
The anchor customer is Medicaid. Federal regulation, 42 CFR 431.53, has long required state Medicaid programs to assure transportation for beneficiaries to and from medical care, and Congress wrote that assurance into the Medicaid statute itself in the Consolidated Appropriations Act of 2021. The benefit covers roughly 104 million trips a year at a cost of nearly $3 billion, according to summaries of program data cited by the Kaiser Family Foundation and PBS NewsHour reporting. That is less than 1% of total Medicaid spending, yet it stands between millions of people and their care: Health Management Associates' analysis of federal data found 3 to 4 million Medicaid beneficiaries used NEMT each year between 2018 and 2021, about 4 to 5% of all beneficiaries.
The work is concentrated in a handful of brokers. Brokers manage roughly 70% of all Medicaid transportation trips in the United States, according to industry reporting on the 2026 broker market. ModivCare, formerly LogistiCare, remains the largest: it coordinates 35 million trips a year across more than 6,500 providers and reports a 98% trip completion rate, while its own releases have put its annual volume above 75 million trips to 30 million patients across its wider supportive-care business. MTM, formally Medical Transportation Management, schedules more than 25 million trips a year for over 13 million members and has grown by acquiring Access2Care and Veyo. SafeRide Health, the technology-led broker, was projected to coordinate more than 12 million rides in 2026. When a broker of that size changes a routing rule, thousands of small fleets feel it the same week.
The technology layer is where the margin lives, and where it leaks. A good dispatch board does four things at once: it batches trips by geography and time window, it matches vehicle type to patient need — ambulatory, wheelchair, stretcher, bariatric — it gives the driver a route that survives traffic and a late discharge, and it produces a clean, auditable record for the payer. A bad one does none of them, and the costs show up everywhere except the line item a manager watches. Fleet research puts average vehicle downtime at $448 to $760 per vehicle per day. A van that waits an hour at a clinic because the return trip was never sequenced is not just late; it is a second trip that cannot be run, a driver paid for idle time, and a patient who learns not to trust the next booking.
Rideshare changed the shape of the problem without solving it. Uber Health and Lyft Healthcare let a hospital, plan, or broker book a standard car for an ambulatory patient who needs no special vehicle, no app, and no credit card — the coordinator books, the patient gets a text. Lyft Healthcare reports that it is enrolled as a Medicaid provider in 21 states, covers more than 62% of Medicaid beneficiaries in those states, and has cut partner transportation costs by an average of 32%, according to Lyft Business figures cited in 2026 coverage. Oregon's recent rethink of its program found SafeRide Health's Uber and Lyft trips running at 98.7% on-time performance with a 4.8 out of 5 average ride rating in 2025. For a same-day, low-acuity trip in a city, that is hard to beat.
The counterargument is real, and any honest routing pitch has to carry it. Rideshare does not do wheelchairs, stretchers, or dialysis chairs. It does not do the patient who needs a driver to walk to the door, wait, and help with the steps. It does not serve the rural county where no driver is circling. And the broker model itself is under strain: ModivCare filed for Chapter 11 bankruptcy protection in August 2025 carrying more than $1.4 billion in debt, with declining Medicaid reimbursement rates cited as a heavy contributor. A market that depends on a few large brokers paying thin rates is a market where a small fleet's best software still cannot fix a bad contract. Fraud controls add a second pressure: several large states now require GPS verification, and providers are paid only for loaded miles — the miles with a patient aboard — not for the empty return, the no-show, or the trip refused at the door.
That is why the analysis points to routing as the durable edge rather than fleet size. A fleet that can prove, trip by trip, that it completed 98% of its work, that its vehicles ran full in both directions, and that its billing matches its GPS trail can win broker work when rates tighten and can survive a broker's collapse by moving to the next payer. A fleet that cannot prove it will be cut first, because it is the easiest to cut. Software that produces that proof — clean scheduling, honest ETAs, a record a payer can audit without a phone call — is not overhead. It is the credential that keeps the vans rolling.
The implication for a buyer in this market is plain. Do not ask first how many vehicles a company runs. Ask how many of its trips run on a route that was planned before the driver started the engine, how many empty miles sit between paid trips, and how many patients missed care last month for a reason the dispatch board could have prevented. The answers to those three questions describe the business. Everything else is paint.
Sources: ResearchAndMarkets, Non-Emergency Medical Transportation Global Strategic Business Report 2025, via Business Wire, August 2025 ($16.2 billion in 2024; $24.3 billion by 2030; 7.0% CAGR).; 42 CFR 431.53 and Consolidated Appropriations Act of 2021, Section 209, as summarized by the Centers for Medicare & Medicaid Services and Medicaid.gov.; Kaiser Family Foundation and PBS NewsHour figures for roughly 104 million trips a year at nearly $3 billion, under 1% of Medicaid spending, and Health Management Associates analysis of CMS data (3–4 million users a year, 2018–2021, 4–5% of beneficiaries), as compiled by RouteGenie and Ryde Central, 2026.; NEMT Platform, broker market reporting, 2026 (brokers manage roughly 70% of Medicaid trips; ModivCare 35 million trips, 6,500+ providers, 98% completion; SafeRide Health 12 million rides projected for 2026).; ModivCare company releases (more than 75 million trips annually across its supportive-care business) and MTM company reporting via iCabbi (more than 25 million trips a year, 13 million members; acquisitions of Access2Care and Veyo).; Fleet downtime of $448–$760 per vehicle per day, Fleet Maintenance, cited by Sovereign Transportation Insurance.; Lyft Healthcare state enrollment, beneficiary coverage, and 32% average partner cost reduction, Lyft Business figures cited by DisabilityHelp, 2026; SafeRide Health Oregon on-time performance of 98.7% and 4.8/5 rating, SafeRide Health white paper on rethinking NEMT in Oregon.; ModivCare Chapter 11 filing, August 2025, more than $1.4 billion in debt, as reported by MobiSoft InfoTech.